MYO insider trading
NYSE American HealthcareMYOMO, INC.: insider trade history from SEC Form 4 filings.
About MYOMO, INC.
Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, Germany, and internationally. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living. It also provides MyoPro 2 that includes control technology, configuration software and user interface, and pop-out battery for extended use of the brace; and MyoPro2+, which comprises 3D printed orthotics capability, software enhancements, and a design for donning and doffing of the device. Its products are designed to help improve function in adults and adolescents with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury, and other neurological disorders. The company sells its products through various sales channels, including orthotics and prosthetics providers, the veteran's administration, and distributors. Myomo, Inc. was incorporated in 2004 and is headquartered in Burlington, Massachusetts.
Company website: myomo.com
MYO insider activity at a glance
FilingIQ tracks 319 insider transactions for MYO in filings since Jun 13, 2017. The most recent transaction is dated Sep 11, 2026.
Across the full history, 45 open-market purchases
and 26 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
The average FilingIQ composite score on MYO insider trades is 57.9/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.
Latest MYO Form 4 filings
Most recent disclosures. Sign up to filter by score, transaction code, or insider role.
Other Healthcare tickers with recent insider activity
Frequently asked
- How many insider trades does FilingIQ track for MYO?
- FilingIQ tracks 319 Form 4 insider transactions for MYO (MYOMO, INC.), covering filings from Jun 13, 2017 onwards. 14 of those are dated within the last 90 days.
- Are MYO insiders net buyers or net sellers?
- Across the full Form 4 history for MYO, 45 transactions (14%) were open-market purchases and 26 (8%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does MYO insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ normalises insider identity across reporting variations and scores discretionary open-market purchases and sales on its multi-factor composite model.
- What sector is MYO in?
- MYOMO, INC. (MYO) is classified in the Healthcare sector, specifically Medical Devices, with a current market capitalisation of $26.54M.
Methodology & sources
Every MYO insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.